JKSM.OTC.PinkJacksam CORP

10-Q: Jacksam Corporation Reports Mixed Q2 Results Amid Restructuring Efforts

Sentiment:

Quarterly Report (Form 10-Q)


Jacksam Corporation's Q2 2024 shows a decrease in revenue compared to the previous year, but also a net income due to the reversal of forfeited stock-based compensation.

Capital raiseThe company anticipates that it will need additional financing to continue as an ongoing entity over the next 12 months.Historically, it has mostly relied upon convertible notes payable and cash flows from operations to finance its operations and growth.Management may raise additional capital by retaining net earnings or through future private offerings of the Company's stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing.
Worse than expectedThe company's revenue decreased compared to the previous year.

Summary

  • Jacksam Corporation's Q2 2024 revenue decreased to $136,312 from $402,610 in Q2 2023.
  • The company reported a net income of $55,331 for Q2 2024, compared to a net loss of $1,645,346 in Q2 2023, primarily due to the reversal of forfeited stock-based compensation.
  • For the six months ended June 30, 2024, revenue was $431,645, down from $1,031,035 in the same period last year.
  • The net loss for the six months ended June 30, 2024, was $491,568, compared to a net loss of $1,589,917 for the same period in 2023.
  • The company's cash and cash equivalents stood at $67,624 as of June 30, 2024.
  • The company is dependent on additional financing to continue as an ongoing entity over the next 12 months.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company achieved net income in Q2, revenue is down, and there are significant concerns about liquidity and the need for additional financing. The material weakness in internal controls is also a negative factor.

Positives

  • The company reported a net income of $55,331 for Q2 2024, compared to a net loss of $1,645,346 in Q2 2023.
  • Net loss for the six months ended June 30, 2024, decreased to $491,568 from $1,589,917 for the same period in 2023.
  • The company reversed $197,531 of expense related to forfeited shares issued to consultants.
  • The company re-negotiated a transaction with a lender and was no longer in default as of December 31, 2023, and as of the date of this report.

Negatives

  • Q2 2024 revenue decreased to $136,312 from $402,610 in Q2 2023.
  • Six-month revenue decreased to $431,645 from $1,031,035 year-over-year.
  • The company has negative working capital and recurring losses.
  • The company does not have a source of revenues sufficient to cover its operating costs.
  • The company is dependent on additional financing to continue as an ongoing entity over the next 12 months.
  • The company's disclosure controls and procedures were ineffective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SECs rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Risks

  • The company's operations are subject to financial, operational, regulatory, and other risks, including the potential risk of business failure.
  • The company has negative working capital, recurring losses, and does not have a source of revenues sufficient to cover its operating costs.
  • The company is dependent on additional financing to continue as an ongoing entity over the next 12 months.
  • The company is in a lawsuit with a previous supplier regarding defected cartridges, and the amount of possible losses is not reasonably estimable.
  • The company's disclosure controls and procedures were ineffective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SECs rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
  • There was a material weakness in our internal control over financial reporting as of June 30, 2024. This conclusion is due to identified control deficiencies around the identification of errors during year end resulting in material adjusting journal entries as well as a lack of a formal policy for the approval, identification and authorization of related party transactions.

Future Outlook

The company anticipates needing additional financing to continue as an ongoing entity over the next 12 months, and its future capital requirements and the adequacy of available funds will depend on many factors.

Management Comments

  • Management believes that its assumptions are based upon reasonable data derived from and known about its business and operations.
  • Management concluded there was a material weakness in our internal control over financial reporting as of June 30, 2024.

Industry Context

The company operates in the cannabis, hemp, and CBD industries, which are subject to evolving regulations and market dynamics. The company's performance is influenced by the level of cannabis legalization in various jurisdictions.

Comparison to Industry Standards

  • The document does not provide enough information to compare Jacksam Corporation's results to specific industry standards or comparable companies.
  • A thorough comparison would require benchmarking against competitors in the vaporizer cartridge filling and capping machine market, considering factors like market share, revenue growth, and profitability.
  • Without specific competitor data, it's difficult to assess whether Jacksam's performance is above or below industry averages.

Legal Proceedings

  • The Company has a pending lawsuit with one of its previous suppliers regarding defected cartridges.

Related Party Transactions

  • Mark Adams, CEO, invested $250,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 1,388,885, which have yet to be issued for a conversion value of $277,778.
  • The Companys former VP of sales also invested $100,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 555,556, which have yet to be issued for a conversion value of $111,111.

Stakeholder Impact

  • Shareholders face the risk of dilution if the company raises additional capital through equity offerings.
  • Employees' job security is uncertain due to the company's financial difficulties.
  • Customers may be concerned about the company's ability to fulfill orders and provide ongoing support.
  • Suppliers may face delays in payments or potential losses if the company's financial situation worsens.
  • Creditors face the risk of default if the company is unable to meet its debt obligations.

Next Steps

  • The company needs to secure additional financing to continue operations.
  • The company needs to address the material weakness in internal control over financial reporting.
  • The company needs to manage the pending lawsuit with the previous supplier.
  • The company needs to execute its business plan and attain profitable operations.

Key Dates

DateDescription
1989-09-21Company incorporated in the State of Nevada as Fulton Ventures, Inc.
2018-09-14Merger closed, and the company began operating under the control of current management.
2020-06-02Company received $150,000 under the Small Business Administrations Economic Injury Disaster Loan.
2021-09-29Company entered into a Revenue Loan and Security Agreement with an investor for up to a total amount of $1,000,000.
2022-02-02Company entered into a lease agreement for office space.
2023-03-30Company entered into a line of credit agreement with a principal amount of $50,000.
2024-01-05Company and Think Capital Partners, LLC entered into a Security Purchase Agreement.
2024-06-30End of the quarterly period.
2024-08-14Date through which management has evaluated events for disclosure.
2024-08-19Date of report signature.

Keywords

Jacksam Corporation, Convectium, financial results, quarterly report, revenue, net loss, cannabis industry, cartridge filling machines, capital resources, liquidity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.